Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1972-01-01 (54 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANTIBES (06160), Alpes-Maritimes
PHARMACIE PONROY-CHASPOUL : revenue, balance sheet and financial ratios
PHARMACIE PONROY-CHASPOUL is a French company
founded 54 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANTIBES (06160),
this company of category PME
shows in 2020 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PONROY-CHASPOUL (SIREN 782470975)
Indicator
2023
2022
2020
2019
2018
2017
Revenue
N/C
N/C
2 239 726 €
2 311 450 €
2 363 481 €
2 379 229 €
Net income
123 009 €
165 320 €
89 131 €
14 615 €
59 359 €
90 478 €
EBITDA
N/C
N/C
167 821 €
23 501 €
66 476 €
80 207 €
Net margin
N/C
N/C
4.0%
0.6%
2.5%
3.8%
Revenue and income statement
In 2023, PHARMACIE PONROY-CHASPOUL generates positive net income of 123 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 90 k€ -> 123 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
123 009 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 94%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
93.884%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.998%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2022
2023
Debt ratio
34.028
27.495
18.648
150.528
91.839
93.884
Financial autonomy
40.936
44.7
48.897
24.841
32.555
25.998
Repayment capacity
1.746
1.574
4.622
2.822
None
None
Cash flow / Revenue
2.132%
2.363%
0.584%
4.645%
None%
None%
Sector positioning
Debt ratio
93.882023
2020
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of PHARMACIE PONROY-CHASPOUL (93.88) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
26.0%2023
2020
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE PONROY-CHASPOUL (26.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
2.82 years2020
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.3 years
Good
In 2020, the repayment capacity of PHARMACIE PONROY-CHASPOUL (2.82) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.37. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2022
2023
Liquidity ratio
129.996
173.674
179.521
216.914
216.151
164.369
Interest coverage
1.183
1.644
3.515
0.887
None
None
Sector positioning
Liquidity ratio
164.372023
2020
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average-24 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE PONROY-CHASPOUL (164.37) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
0.89x2020
2020
Q1: 0.68x
Med: 3.87x
Q3: 8.37x
Average
In 2020, the interest coverage of PHARMACIE PONROY-CHASPOUL (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PONROY-CHASPOUL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2022
2023
Operating WCR
263 738 €
307 513 €
263 968 €
291 008 €
0 €
0 €
Inventory turnover (days)
39
42
41
44
0
0
Customer payment term (days)
5
8
6
4
0
0
Supplier payment term (days)
42
46
40
40
0
0
Positioning of PHARMACIE PONROY-CHASPOUL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE PONROY-CHASPOUL is estimated at
1 451 441 €
(range 882 691€ - 2 040 401€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
882k€1451k€2040k€
1 451 441 €Range: 882 691€ - 2 040 401€
NAF 5 année 2023
Valuation method used
Net Income Multiple
123 009 €
×
11.8x
=1 451 442 €
Range: 882 691€ - 2 040 401€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PONROY-CHASPOUL with other companies in the same sector:
Frequently asked questions about PHARMACIE PONROY-CHASPOUL
What is the revenue of PHARMACIE PONROY-CHASPOUL ?
The revenue of PHARMACIE PONROY-CHASPOUL in 2020 is 2.2 M€.
Is PHARMACIE PONROY-CHASPOUL profitable?
Yes, PHARMACIE PONROY-CHASPOUL generated a net profit of 123 k€ in 2023.
Where is the headquarters of PHARMACIE PONROY-CHASPOUL ?
The headquarters of PHARMACIE PONROY-CHASPOUL is located in ANTIBES (06160), in the department Alpes-Maritimes.
Where to find the tax return of PHARMACIE PONROY-CHASPOUL ?
The tax return of PHARMACIE PONROY-CHASPOUL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PONROY-CHASPOUL operate?
PHARMACIE PONROY-CHASPOUL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart